2-Chloro-4,6-dimethoxy-1,3,5-triazine, 98.0%, 100g

3H-Cyclopenta[c]quinoline, 4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-tetrahydro-, (3aS,4R,9bR)-, 99%, 10mg

2-Fluoro-4-(trifluoromethoxy)benzoyl chloride, 5g

tert-Butyl 2-aminobenzoate, 95.0%, 25g

4'-chloro-3-(3-pyrrolinomethyl) benzophenone, 97.0%, 1g

L-a-tert-Butylglycine-tert-butyl ester hydrochloride, 95.0%, 25g

(S)-(+)-NBD-Py-NCS [=(S)-(+)-4-(3-Isothiocyanatopyrrolidin-1-yl)-7-nitro-2,1,3-benzoxadiazole] [HPLC Labeling Reagent for e.e. Determination]>98.0%(HPLC)100mg

Colonne capillaire GC ROTI®Cap-1 MS, 12 m, 0,20 mm, 0,35 µm, 1 pièce(s)

(S)-4-BENZYL-2-(ISOQUINOLIN-1-YL)-4,5-DIHYDROOXAZOLE, 95%, 250mg

5-Methyl-1H-pyrrole-2-carbaldehyde, 95.0%, 5g

4,7-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[c][1,2,5]thiadiazole, 95.0%, 10g

(R)-4-Amino-3-fluoro-2-methylbutan-2-ol, 97%, 100mg

(R)-benzyl 1-amino-3-phenylpropan-2-ylcarbamate, 95.0%, 1g